| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Sotevtamab | AB-sCLU mAB; 16B5; AB-16B5 | Phase 2 Clinical | National Research Council Biotechnology Research Institute | Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasm Metastasis; Solid tumours | Details |